Poor economics - Transforming challenges in transfusion medicine and science into opportunities.
作者信息
Smit Sibinga Cees Th, Abdella Yetmgeta E, Seghatchian Jerard
机构信息
International Development of Transfusion Medicine, University of Groningen, The Netherlands; Director IQM Consulting for International Development of Quality Management in Transfusion Medicine, Zuidhorn, The Netherlands.
Access to Medicines and Health Technologies, Universal Health Coverage - Health System, WHO Regional Office for the Eastern Mediterranean, Cairo, Egypt.
出版信息
Transfus Apher Sci. 2020 Apr;59(2):102752. doi: 10.1016/j.transci.2020.102752. Epub 2020 Feb 28.
The prospect of cryopreservation of cellular components in the low and medium income (poor economics) part of the world absolutely needs a solid and sustainable infrastructure to build on in line with science, technology and globalization, based on rational thinking, standardization and harmonization of future advances we are currently witnessing in limited parts of the world. With the stepwise development of the healthcare stimulated by the 2012 UN Universal Health Coverage (UHC) program and supported by WHO Model List of Essential Medicines (EM) and Essential in vitro Diagnostics (ED), a slowly growing number of countries will reach a point where quality cryopreservation of cellular components becomes feasible as an advance for implementing specific health care visions, policies and strategies in line with the Sustainable Development Goals 2016-2030.
Zotero 插件